CMR FigSearch
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by O'Hara, C. M.
Right arrow Articles by Miller, J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by O'Hara, C. M.
Right arrow Articles by Miller, J. M.

Clinical Microbiology Reviews, October 2000, p. 534-546, Vol. 13, No. 4
0893-8512/00/$04.00+0

Classification, Identification, and Clinical Significance of Proteus, Providencia, and Morganella

Caroline Mohr O'Hara,1,* Frances W. Brenner,2 and J. Michael Miller1

Hospital Infections Program1 and Foodborne and Diarrheal Diseases Branch, Division of Bacterial and Mycotic Diseases,2 Centers for Disease Control and Prevention, Atlanta, Georgia

This review presents the current taxonomy of the genera Proteus, Providencia, and Morganella, along with the current methods for the identification of each species within the three genera, incorporating both conventional biochemical and commercial methods. While all of these organisms are ubiquitous in the environment, individual case reports and nosocomial outbreak reports that demonstrate their ability to cause major infectious disease problems are presented. Lastly, anticipated antimicrobial susceptibility patterns are reviewed. Many of these organisms are easily controlled, but the advent of newer and more powerful antimicrobial agents has led to some problems of which laboratorians need to be aware.

* Corresponding author. Mailing address: Mailstop C16, Centers for Disease Control and Prevention, Atlanta, GA 30333. Phone: (404) 639-2316. Fax: (404) 639-3241. E-mail: cmo1{at}cdc.gov.

Clinical Microbiology Reviews, October 2000, p. 534-546, Vol. 13, No. 4
0893-8512/00/$04.00+0


This article has been cited by other articles:



Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Antimicrob. Agents Chemother. Clin. Vaccine Immunol.
J. Clin. Microbiol. ALL ASM JOURNALS

Copyright © 2000 by the American Society for Microbiology. All rights reserved.